IBOGF (Universal Ibogaine) Net Income: $-1.06 Mil (TTM As of Apr. 2025)

What is Universal Ibogaine Net Income?

Universal Ibogaine IBOGF -1.07% Net Income is $-1.06 Mil as of Apr. 2025.

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Universal Ibogaine's Net Income for the three months ended in Apr. 2025 was $-0.05 Mil. Its Net Income for the trailing twelve months (TTM) ended in Apr. 2025 was $-1.06 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Universal Ibogaine's Earnings per Share (Diluted) for the three months ended in Apr. 2025 was $-0.00.

Universal Ibogaine (OTCPK:IBOGF) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Universal Ibogaine's Earnings per Share (Diluted) (EPS) for the quarter that ended in Apr. 2025 is calculated as

Earnings per Share (Diluted) (Q: Apr. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-0.047	-	0)	/	308.611
	=	-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.

Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.

Universal Ibogaine Net Income Related Terms

Universal Ibogaine Net Income Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's Net Income can be seen below:

Universal Ibogaine Net Income Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Jul24

Net Income

Get a 7-Day Free Trial

-0.09

-0.23

-8.11

-1.81

-1.50

Universal Ibogaine Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25
Net Income	Get a 7-Day Free Trial															-0.63	-0.55	-0.25	-0.21	-0.05

Universal Ibogaine Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Universal Ibogaine's Net Income for the fiscal year that ended in Jul. 2024 is calculated as

	Net Income		(A: Jul. 2024 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	-1.496	+	0	+	0	+	0
=	-1.50

Universal Ibogaine's Net Income for the quarter that ended in Apr. 2025 is calculated as

	Net Income		(Q: Apr. 2025 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	-0.047	+	0	+	0	+	0
=	-0.05

Net Income for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.06 Mil.

Frequently Asked Questions Learn more about Net Income →

What does a Net Income of $-1.06 Mil mean?

Universal Ibogaine (IBOGF) has a Net Income of $-1.06 Mil as of Apr. 2025. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Universal Ibogaine and its competitors.

Is Universal Ibogaine's Net Income too high?

Universal Ibogaine's current Net Income is $-1.06 Mil.

How does Universal Ibogaine's Net Income compare to LABT and CALC?

Universal Ibogaine's Net Income of $-1.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Income for a Biotechnology company?

A good Net Income depends on the Biotechnology industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Income mean?

A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Universal Ibogaine and its competitors. Universal Ibogaine's current Net Income is $-1.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Universal Ibogaine stock overvalued right now?

Universal Ibogaine (IBOGF) has a current Net Income of $-1.06 Mil. The current Net Income is $-1.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Income calculated?

Net Income is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current Net Income is $-1.06 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Industry Healthcare Biotechnology

Comparable Companies LABT CALC LNAI BCDA PBM BOLT IMNN CURX BIVI PMCB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL ONC RVMD XKRX:068270

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2

Website https://www.universalibogaine.com

Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.